KYBELLA® (deoxycholic acid) injection is the first and only FDA-approved injectable treatment that is used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called, "double chin". It is not known if KYBELLA® is safe and effective in children less than 18 years of age. It is not known if KYBELLA® is safe and effective for use outside of the submental area. Between one to 4 treatments may be needed for your desired results.
Each Kybella® treatment for reduction of double chin or submental fat takes less than 20 minutes.
There is minimal discomfort during the treatment and mild swelling for 2-3 days following the.
Actual patients. Unretouched photos taken before treatment and after final treatment. Individual results may vary.
Multiple injections under the chin per treatment; up to 6 treatments spaced at least 1 month apart. 59% of patients received 6 KYBELLA® treatments in clinical studies. Treatment is tailored to the amount of fat under the chin and aesthetic goals.
68.2% of patients treated with KYBELLA® in 2 clinical studies had some/moderately better improvement, compared with 20.5% of patients treated with placebo (70% vs 18.6% in Study 1, 66.5% vs 22.2% in Study 2).
16% of patients treated with KYBELLA® in 2 clinical studies had significant/a great deal better improvement, compared with 2% of patients treated with placebo (13.4% vs less than 0% in Study 1, 18.6% vs 3% in Study 2).